First Trust Advisors LP Karyopharm Therapeutics Inc. Transaction History

First Trust Advisors LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$8.11 - $11.11 $470,809 - $644,968	-58,053 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$9.85 - $17.69 $6,589 - $11,834	669 Added 1.17%	58,053 $611,000
Q4 2020 Feb 02, 2021	SELL	$14.15 - $17.19 $375,866 - $456,617	-26,563 Reduced 31.64%	57,384 $888,000
Q3 2020 Nov 05, 2020	SELL	$14.14 - $19.71 $133,594 - $186,220	-9,448 Reduced 10.12%	83,947 $1.23 Million
Q2 2020 Jul 22, 2020	BUY	$16.6 - $25.25 $1.55 Million - $2.36 Million	93,395 New	93,395 $1.77 Million
Q2 2019 Jul 30, 2019	SELL	$4.32 - $6.43 $170,765 - $254,171	-39,529 Closed	0 $0
Q1 2019 May 09, 2019	SELL	$4.12 - $10.25 $530,000 - $1.32 Million	-128,641 Reduced 76.49%	39,529 $231,000
Q4 2018 Feb 07, 2019	BUY	$8.2 - $16.95 $1.38 Million - $2.85 Million	168,170 New	168,170 $1.58 Million

59.6M

547K

67K

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $512M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

Stay updated on First Trust Advisors LP with notifications on news.